BC Week In Review | Apr 22, 2013
Clinical News

Immunomedics preclinical data

In a mouse model of lymphoma, 5 doses of 43 µg IV (19)-3s led to a survival rate of 75% compared to 0% for mice treated with peripheral blood mononuclear cells (PBMCs). Additionally, 63% of...
Items per page:
1 - 1 of 1